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Introduction
Cells  are  continuously  exposed  to  endogenous  and 
exogenous  agents  that  damage  DNA  and  compromise 
genomic integrity (Munro, 1970). To minimize the harm-
ful impact of such continuous damage, cells have evolved 
DNA damage response (DDR) mechanisms that include 
DNA repair and processes regulating cell cycle progres-
sion  (van  Gent  et  al.,  2001;  Jackson  &  Bartek,  2009). 
The  coordinated  interplay  of  the  DDR  mechanisms  is 
important  to  secure  cellular  fidelity  and  to  avoid  the 
development of chromosomal instability. A DNA double-
strand break (DSB) is arguably one of the most delete-
rious lesions. Although DSBs arise less frequently than 
single-strand  breaks  (SSBs),  they  are  potentially  more 
significant. DSBs also arise following radiation exposure 
and, indeed, understanding the DDR process operating 
in response to DSBs is important for understanding the 
response to ionising radiation (IR). Several studies are 
aimed to investigate the interplay of DSB repair and cell 
cycle control mechanisms to understand how cell cycle 
progression is regulated in the presence of DSBs. From 
these studies, it became obvious that cell cycle control 
mechanisms  exhibit  limitations  which  can  contribute 
to the development of genomic instability. For example, 
we and others have found that the G1/S checkpoint is 
not fully initiated until several hours post IR, allowing 
many cells to enter S phase with unrepaired DSBs and 
other damages (Linke et al., 1997b; Cann & Hicks, 2006; 
Deckbar et al., 2010). The G2/M checkpoint also has limi-
tations, although they are distinct in nature, representing 
a failure to be activated after low doses (Deckbar et al., 
2007; Krempler et al., 2007; Lobrich & Jeggo, 2007).
REVIEW ARTICLE
Understanding the limitations of radiation-induced cell cycle 
checkpoints
Dorothee Deckbar1, Penny A. Jeggo2, and Markus Löbrich1
1Darmstadt University of Technology, Radiation Biology and DNA Repair, Darmstadt, Germany, and 2Genome Damage 
and Stability Centre, University of Sussex, East Sussex, UK 
Abstract
The DNA damage response pathways involve processes of double-strand break (DSB) repair and cell cycle checkpoint 
control to prevent or limit entry into S phase or mitosis in the presence of unrepaired damage. Checkpoints can 
function to permanently remove damaged cells from the actively proliferating population but can also halt the cell 
cycle temporarily to provide time for the repair of DSBs. Although efficient in their ability to limit genomic instability, 
checkpoints are not foolproof but carry inherent limitations. Recent work has demonstrated that the G1/S checkpoint 
is slowly activated and allows cells to enter S phase in the presence of unrepaired DSBs for about 4–6 h post irradiation. 
During this time, only a slowing but not abolition of S-phase entry is observed. The G2/M checkpoint, in contrast, is 
quickly activated but only responds to a level of 10–20 DSBs such that cells with a low number of DSBs do not initiate 
the checkpoint or terminate arrest before repair is complete. Here, we discuss the limitations of these checkpoints in 
the context of the current knowledge of the factors involved. We suggest that the time needed to fully activate G1/S 
arrest reflects the existence of a restriction point in G1-phase progression. This point has previously been defined 
as the point when mitogen starvation fails to prevent cells from entering S phase. However, cells that passed the 
restriction point can respond to DSBs, albeit with reduced efficiency.
Keywords:  Cell cycle checkpoints, double-strand break repair, ionising radiation, restriction point, genomic 
instability
Address for Correspondence: M. Löbrich, Darmstadt University of Technology, Radiation Biology and DNA Repair, Schnittspahnstrasse 13, 
Darmstadt, 64287 Germany. E-mail: lobrich@bio.tu-darmstadt.de; Prof. Penny A. Jeggo, University of Sussex, Genome Damage and Stability 
Centre, Science Park Road, Brighton, BN1 9RQ, United Kingdom. E-mail: p.a.jeggo@sussex.ac.uk
(Received 02 February 2011; revised 23 March 2011; accepted 24 March 2011)
Critical Reviews in Biochemistry and Molecular Biology, 2011; 46(4): 271–283
© 2011 Informa Healthcare USA, Inc.
ISSN 1040-9238 print/ISSN 1549-7798 online
DOI: 10.3109/10409238.2011.575764











© 2011 Informa Healthcare USA, Inc.
10.3109/10409238.2011.575764
BBMG
575764272  D. Deckbar et al.
  Critical Reviews in Biochemistry and Molecular Biology
Here, we discuss the limitations of the G1/S and G2/M 
checkpoints  in  the  context  of  the  current  molecular 
knowledge of DSB repair, cell cycle regulation and check-
point control. We first provide a brief summary of the 
current knowledge of DSB repair, then discuss the pro-
cesses that regulate cell cycle progression in an unper-
turbed cell and how DNA damage impacts upon these 
processes. Finally, we discuss the cellular and molecular 
mechanisms  that  underlie  limitations  to  the  damage-
induced checkpoints.
DSB repair mechanisms
DNA repair is the front line response to DNA damage. 
Eukaryotic cells have developed two main mechanisms 
to  repair  DSBs—nonhomologous  end-joining  (NHEJ) 
and  homologous  recombination  (HR).  NHEJ  is  active 
throughout  the  cell  cycle  and  relies  on  rejoining  free 
DNA  ends  without  the  need  for  sequence  homology; 
HR, in contrast, involves the use of a homologous DNA 
sequence  as  a  template  for  resynthesis.  In  yeast,  the 
homologous chromosome can be used allowing HR to 
operate in all cell cycle phases. In contrast, in mammalian 
cells, HR only uses the sister chromatid restricting HR to 
the postreplicational cell cycle phases. However, even in 
G2, the majority of DSB repair occurs via NHEJ with HR 
being restricted to the repair of a subset of DSBs locating 
to heterochromatic regions (Beucher et al., 2009). In con-
trast to its limited role in G2, HR has a major role during S 
phase, both in repairing replication-associated DSBs and 
in promoting replication fork restart.
The detailed mechanisms of DSB repair have been the 
subject of several excellent reviews (Sancar et al., 2004; 
Helleday et al., 2007; Mahaney et al., 2009; Warmerdam & 
Kanaar, 2010). Briefly, during NHEJ, the free DSB ends are 
recognized and bound with high affinity by the Ku70/Ku80 
heterodimer, which forms a ring-like structure enabling it 
to thread onto a DNA end, thereby protecting the ends 
from diffusing apart and undergoing nucleolytic degrada-
tion. Ku70/Ku80 stimulates the binding of the catalytic 
subunit  of  the  DNA-dependent  protein  kinase  (DNA-
PKcs) to the outer end of the DNA which, together with 
Ku70/Ku80, constitutes the active DNA-PK holoenzyme. 
The  subsequent  trans-autophosphorylation  of  DNA-PK 
across the break site results in a conformational change 
and  exposure  of  the  DSB  ends  promoting  recruitment 
of the Lig4/XRCC4/XLF complex and finally ligation. IR 
induces  complex  DSBs  that  possess  additional  lesions 
such  as  SSBs,  base  damages,  abasic  sites  or  phospho-
glycosylates in close proximity to the DSB. Furthermore, 
chemicals such as topoisomerase II inhibitors and other 
drugs used for tumor treatment induce DSBs with cova-
lently bound proteins or with single-stranded overhangs. 
In this case, the DSB is not directly ligatable and needs 
further  processing  prior  to  ligation.  Such  processing 
involves nucleases, such as Artemis, as well as additional 
enzymes that include polynucleotide kinase (PNK), DNA 
polymerases  μ  and  λ  and  Werner’s  syndrome  helicase 
(WRN; reviewed in Mahaney et al., 2009), which interact 
in concert with DNA-PK to remove these “bulky” lesions.
HR is initiated by the binding of the Mre11-Rad50-
Nbs1 (MRN) complex to the free DSB ends. Subsequent 
resection is promoted by CtIP and the MRN complex and 
extended by Exo1 and Dna2 supported by the Bloom’s 
syndrome helicase (BLM). However, the exact orchestra-
tion of nucleases and helicases in the course of resection 
remains  unclear  (Mimitou  &  Symington,  2009;  Mazón 
et al., 2010). The resulting 3’-overhangs, which can extend 
over several hundred bases, are stabilized by the single-
strand binding protein, replication protein A (RPA), which 
is subsequently replaced by the recombinase Rad51. After 
homology searching, this nucleoprotein filament invades 
into the double-helix of the homologous sister chroma-
tid. Using the free 3’-OH as a primer, DNA synthesis is 
performed by DNA-polymerase δ and η and ligation by 
DNA-Ligase I. The resulting Holliday Junctions are finally 
resolved by the helicase BLM in complex with TopIIIα/
RMI1 (Cheok et al., 2005; Chu & Hickson, 2009). Recent 
studies have further identified Mus81-Eme,1 GEN1 and 
SLX1 as potential Holliday Junction resolvases (Ip et al., 
2008; Fekairi et al., 2009; Muñoz et al., 2009; Svendsen 
et al., 2009; Svendsen & Harper, 2010).
Cell cycle regulation and cell cycle 
checkpoints
The  eukaryotic  cell  cycle  consists  of  four  phases  and 
traversal from one to the other is regulated by Cyclins 
and Cyclin-dependent kinases (Cdks). Cyclins are small 
proteins  that  are  expressed  and  degraded  throughout 
the cell cycle in an oscillating manner. They gain their 
regulatory power by binding and activating Cdks, which 
phosphorylate a plethora of downstream substrates that 
regulate cell cycle progression.
DNA damage can be particularly harmful in certain 
cell  cycle  phases.  For  example,  during  S  phase,  DNA 
damage  can  interfere  with  replication  fork  progres-
sion and simple base damages can result in base mis-
pairing causing point mutational changes. DNA–DNA or 
DNA–protein cross-links can lead to a distortion of the 
double-helix and also impede replication fork progres-
sion. Furthermore, unrepaired DSBs, SSBs and certain 
base damages can lead to replication fork stalling or col-
lapse, which can compound the damage causing further 
DSBs  and  chromosome  breaks.  During  cell  division, 
chromosomal damage can result in loss of genetic mate-
rial causing genetic alterations or even the death of the 
daughter cells. It is, therefore, not surprising that cells 
have developed tightly regulated mechanisms to control 
cell cycle progression in the presence of DSBs.
Following the induction of DNA damage, particularly 
DSB  formation,  cell  cycle  progression  is  interrupted 
to provide time for the removal of the damage. This is 
achieved  by  the  activation  of  cell  cycle  checkpoints 
which target the Cyclin/Cdk complexes that normally 
promote cell cycle progression. Cell cycle checkpoints Limitations of radiation-induced cell cycle checkpoints  273
© 2011 Informa Healthcare USA, Inc. 
exist at the G1/S and G2/M boundary and are thought 
to prevent cells from replication or undergoing mito-
sis,  respectively,  in  the  presence  of  DNA  damage. 
Furthermore, DSB induction can cause slowing of repli-
cation by locally inhibiting replication fork progression 
and  new  origin  firing.  Deficiencies  in  these  S-phase 
checkpoints result in a radio-resistant DNA-synthesis 
(RDS) phenotype, i.e. cells are not able to stop synthe-
sis in the presence of DSBs, which is a typical feature 
of cells from patients with chromosome instability syn-
dromes such as ataxia telangiectasia (AT) or Nijmegen 
breakage syndrome (NBS; Falck et al., 2001, 2002). In 
contrast to these checkpoints that are directly induced 
by DNA damage, mitotic spindle checkpoints are acti-
vated  indirectly  by  sensing  the  consequences  of  the 
damage, such as incorrect alignment at the equatorial 
plane and/or impaired formation or attachment of the 
spindle fibers at the kinetochores. In the following, we 
will focus on the regulation of the G1/S and the G2/M 
checkpoint.
G1-phase progression and G1/S transition
The replication of the genome represents a process which 
is  initiated  soon  after  mitosis.  At  this  point,  mitogens 
stimulate  the  expression  of  CyclinD  which  associates 
with Cdk4 or 6, depending on the cell type. The result-
ing active CyclinD/Cdk4/6 complex has different targets, 
one of which is the retinoblastoma protein, pRb. In its 
hypophosphorylated state, pRb binds transcription fac-
tors of the E2F family which are required for cell cycle 
progression. As the level of CyclinD/Cdk4/6 complexes 
increases, pRb becomes phosphorylated and progression 
through G1 occurs. At a critical level of phosphorylation, 
E2F is released from pRb. This activates the transcription 
of CyclinE which complexes with Cdk2 to fully release 
pRb  repression  by  further  phosphorylation,  establish-
ing a positive feedback loop. E2F further promotes the 
transcription  of  S-phase  genes.  Thus,  CyclinD/Cdk4/6 
and  CyclinE/Cdk2  together  regulate  S-phase  entry  via 
phosphorylating pRb, which controls pRb binding to E2F 
(Figure 1).
The restriction point is a critical stage during cell cycle 
progression at which the decision is made whether to 
undergo another round of replication or to transiently 
or  permanently  arrest  in  G0/G1.  To  characterize  the 
response of cells at different positions in G1 to mitogen 
deprivation,  3T3  cells  were  serum-starved  for  1 h  and 
the time taken to reach the next mitosis was measured 
(Zetterberg  &  Larsson,  1985).  Cells  that  divided  more 
than  ~3.5 h  before  serum  deprivation  did  not  show  a 
significant delay in cell cycle progression, whereas cells 
that divided less than ~3.5 h before serum deprivation 
displayed a delay of approximately 8 h. This important 
experiment demonstrated that there is only a short time 
window after cell division when the cell is responsive 
to external growth signals. The position in the cell cycle 
when the switch from mitogen-dependent to mitogen-
independent cell cycle progression occurs was termed 
the restriction point. Along with this observation came 
the recognition that pRb is successively phosphorylated 
by Cdks during G1-phase progression and that the loss of 
pRb together with other E2F binding proteins abolishes 
the ability to enter a senescence-like state and increases 
the proliferation rate (Weinberg, 1995; Zetterberg et al., 
1995; Dannenberg et al., 2000; Sage et al., 2000). Thus, 
today the restriction point is, in simple terms, the point 
in  G1-phase  progression  when  pRb  phosphorylation 
exceeds  a  certain  threshold  level  causing  initial  E2F 
release, which then activates the CyclinE/Cdk2 complex 
that leads to further pRb phosphorylation and more E2F 
release (Yao et al., 2008).
In addition to the successive phosphorylation of pRb 
by active Cyclin/Cdk complexes, other factors can also 
impact  upon  S-phase  entry  (Figure  1).  For  example, 
replication origins (ORI) have to be prepared (licensed) 
for replication initiation and a licensing checkpoint has 
been described (Ge & Blow, 2009; Nevis et al., 2009). ORI 
licensing starts in late mitosis/early G1 with the forma-
tion of the pre-replicative complex (pre-RC; Bell & Dutta, 
2002; DePamphilis, 2003; Arias & Walter, 2007). Briefly, in 
mammalian cells, Orc1 binds to ORIs at the M/G1 transi-
tion. This triggers independent recruitment of Cdc6 and 
Cdt1 and finally the Mcm2-7 complex. Disassembly of 
Orc1, Cdc6 and Cdt1 from the chromatin ensues once 
Mcm2-7 is loaded (Rowles & Blow, 1997; Arias & Walter, 
2007). Subsequently, the initiation of replication requires 
the formation of a pre-initiation complex (pre-IC) that 
is initiated by phosphorylation of Mcm2-7 by CyclinE/
Cdk2 and DDK (Dbf4- and Drf1-dependent kinase) and 
recruitment of Cdc45 onto the chromatin (Figure 1). This 
recruitment is thought to be the critical step for the acti-
vation of the Mcm2-7 helicase activity and replication 
initiation. Finally, unwinding of the chromatin enables 
DNA-polymerase α to initiate DNA synthesis and DNA-
polymerase δ to continue replication (reviewed e.g. in 
Bell & Dutta, 2002; Arias & Walter, 2007; Boye & Grallert, 
2009).
To avoid re-replication of the same sequences, which 
would cause chromosomal instability, it is crucial that 
each origin only fires once. This is achieved by a range 
of mechanisms which, at least to some extent, are organ-
ism specific (reviewed e.g. in Arias & Walter, 2007). For 
example, the drosophila ortholog of Cdt1 is targeted for 
proteolysis  following  CyclinE/Cdk2-dependent  phos-
phorylation.  Thus,  free  Cdt1  is  degraded  once  a  cell 
has progressed to late G1 or S phase and CyclinE/Cdk2 
becomes active (Thomer et al., 2004). In other multicel-
lular  organisms,  Geminin  has  been  identified  to  bind 
Cdt1 and prevent interaction between Cdt1 and Mcm2-7 
(Wohlschlegel et al., 2000; Cook et al., 2004). At the tran-
sition from metaphase to anaphase, Geminin is ubiq-
uitinated by APCCdc20 and degraded, allowing renewed 
origin licensing (McGarry & Kirschner, 1998).274  D. Deckbar et al.
  Critical Reviews in Biochemistry and Molecular Biology
G1/S checkpoint induction and its limitations
As  stated  above,  the  G1/S  checkpoint  is  important  to 
prevent damaged cells from entering S phase. To achieve 
this, the induction of DNA damage during G1 leads to 
the activation of signaling cascades which inactivate the 
CyclinD/Cdk4/6 and CyclinE/Cdk2 complexes that regu-
late S-phase entry. Two distinct mechanisms have been 
described (Figure 1; Iliakis et al., 2003; Lukas et al., 2004). 
One pathway involves the phosphorylation of p53 and its 
Figure 1.  G1/S transition and G1/S checkpoint induction. The transition from G1 to S phase is initiated by the increasing mitogen-stimulated 
activity of CyclinD/Cdk4/6 which phosphorylates pRb resulting in the initial release of the E2F transcription factor. This activates a positive 
feedback loop rendering cell cycle progression independent of mitogenic stimulation, an event that has been termed restriction point 
(R-point; blue arrow). The feedback loop involves the upregulation of CyclinE which, in complex with Cdk2, further stimulates E2F release 
and the transcription of genes necessary for S phase. After full pRb phosphorylation, all E2F is released and cells are unable to respond to 
DNA damage via ATM-dependent checkpoint induction (red arrow). In parallel to pRb phosphorylation, replication origins are licensed 
and the pre-replication complex (pre-RC) is formed. Again, through the activity of CyclinE/Cdk2, Cdc45 is loaded onto the chromatin 
forming the pre-initiation complex (pre-IC) which is required for polymerase recruitment. After double-strand break (DSB) induction, 
two parallel checkpoint pathways target the activity of Cyclin/Cdk complexes (indicated in blue symbols). The slower pathway involves the 
stabilization of p53 and transcriptional upregulation of p21 which binds and inhibits the Cyclin/Cdk complexes. The faster pathway acts via 
the activation of Chk2 and the inactivation of Cdc25. Thus, inhibitory phosphates of the CyclinE/Cdk2 complex can no longer be removed. 
The indicated times are estimations and may vary considerably between cell types (see text for details). (See colour version of this figure 
online at www.informahealthcare.com/bmg)Limitations of radiation-induced cell cycle checkpoints  275
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negative regulator Mdm2 by ataxia telangiectasia mutated 
(ATM) and Chk2 causing p53 activation and stabilization. 
p53 then transcriptionally upregulates the expression of 
target genes, of which p21 is critical for inhibiting G1/S 
entry. p21 is a Cdk inhibitor and binds CyclinE/Cdk2 and 
CyclinD/Cdk4/6  complexes.  As  this  pathway  involves 
transcriptional  activation  following  posttranslational 
modifications, its full activation requires several hours 
and is assumed to be especially important for the main-
tenance of G1 arrest by inhibiting pRb phosphorylation. 
A second pathway involves only posttranslational modi-
fications such as phosphorylations and ubiquitinylations 
and is therefore activated more rapidly. This response 
operates  through  ATM-dependent  phosphorylation  of 
Chk2  and  subsequent  destruction  of  the  phosphatase 
Cdc25a, preventing the removal of inhibitory phosphates 
from  Cdk2.  Although  studies  have  shown  that  Chk2-
dependent regulation of Cdc25 can occur after damage 
in G1 phase (Bartek & Lukas, 2007), several studies have 
demonstrated that irradiation of middle or late G1-phase 
cells,  even  with  unphysiologically  high  doses,  does 
not abolish S-phase entry for 4–6 h after IR (Gadbois & 
Lehnert, 1997; Linke et al., 1997b; Cann & Hicks, 2006; 
Deckbar et al., 2010). Thus, up to 4–6 h post IR, only a 
slowing of S-phase entry is observed, even after high irra-
diation doses (e.g. 10 Gy; Figure 2). This, however, repre-
sents a defined damage response as it is abolished in the 
absence of ATM and Chk2.
These findings raise two questions; firstly, why does full 
G1/S arrest take 4–6 h for activation; and, secondly, what 
is the cause for the slowing observed during this time. 
One possibility addressing the first question is that p21 
activation requires posttranslational modifications and 
subsequent transcriptional activation and is, therefore, 
slow in its full activation. However, p21 expression can be 
observed within 2–3 h post IR suggesting that, although 
certainly  a  contributing  factor,  there  may  be  another 
influencing factor. The concept of the restriction point 
is important in this context. Both the activation of the 
p53/p21 and the Chk2/Cdc25 pathways serve to inhibit 
Cdk activity; thus cells ahead of the restriction point may 
already have achieved sufficiently phosphorylated pRb 
that they are unresponsive or have limited sensitivity to 
respond to Cdk inhibition. It should, however, be consid-
ered that the restriction point defined by mitogen stimu-
lation does not correspond to the point where cells can 
no longer respond to DNA damage, which is likely to be 
when pRb is fully phosphorylated following both CyclinD/
Cdk4/6 and CyclinE/Cdk2 activation (see below). Thus, 
although the explanation is not entirely clear, it is evident 
that there is a point 4–6 h before S-phase entry after which 
cells cannot be fully inhibited for S-phase entry and that 
this is consistent with the notion of the timing of a restric-
tion point and is not entirely explained solely by the time 
taken to activate p21.
In considering the mechanistic explanation underly-
ing the second question, i.e. the early slowing in S-phase 
entry, it has to be appreciated that the cells that slowly 
enter S phase are those in late G1 phase. One possibility 
is that this process actually represents an S-phase check-
point rather than a G1/S-phase checkpoint. Thus, cells 
may enter S phase but be slowed by the inhibition of ori-
gin firing. Although it is difficult to rule out the possibility 
that the slow S-phase entry correlates with slow S-phase 
Figure 2.  Limitations of the G1/S checkpoint. The activation of the G1/S checkpoint is a slow but sensitive process. During the first 4–6 h after 
ionising radiation (IR), only a slowing of S-phase entry can be observed, allowing many cells to enter S phase even after high doses. Thus, 
during this time, many cells enter S phase with high double-strand break (DSB) levels. After full checkpoint activation, the G1/S checkpoint 
is sensitive to low DSB levels. The G1/S checkpoint is not necessarily permanent but cells can be released from it; the duration of arrest 
increases with dose. At the time of checkpoint release, most cells have slightly but significantly higher damage levels than unirradiated 
cells. After high doses, the checkpoint is maintained and only a few cells escape checkpoint arrest and enter S phase with elevated DSB 
levels. The figure depicts the S-phase entry of asynchronously irradiated cells. Edu is added prior to irradiation and cells in S phase at the 
time of irradiation are excluded from analysis (i.e. Edu+ cells). BrdU is added after irradiation and the figure shows the staining of BrdU+ 
Edu− cells. (See colour version of this figure online at www.informahealthcare.com/bmg)276  D. Deckbar et al.
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progression, this was not supported by our analysis of the 
progression of early, mid and late S-phase cells (Deckbar 
et al., 2010). Thus, we favor the explanation that the ATM/
Chk2/Cdc25-dependent slowing in S-phase entry repre-
sents a response of G1-phase cells—i.e. the arrest of a 
fraction of cells from entering S phase. Another possibil-
ity is that origin licensing is inhibited or slowed. As late 
G1-phase cells have already licensed many origins, this 
could result in slow S-phase entry if licensing is slowed. 
However, a radiation-induced damage response impact-
ing upon licensing was reported to be independent of 
ATM and Chk2 (Higa et al., 2003), in contrast to the slow-
ing observed in our studies (Deckbar et al., 2010). The 
prevailing evidence, therefore, suggests that within the 
first 4–6 h post IR, a Chk2/Cdc25 process is activated to 
inhibit Cdk activity akin to the process in G2/M phase.
It is striking that a small degree of slowing of S-phase 
entry  can  be  observed  after  very  low  X-rays  doses 
(100  mGy).  Moreover,  there  is  a  clear  dose  response. 
Importantly, the observation of a dose response relation-
ship above 1 Gy, a dose which can activate G1/S arrest 
in all cells after 4–6 h, argues strongly that there is a sen-
sitivity difference between early and late G1-phase cells 
in their ability to undergo checkpoint arrest. Thus, the 
early Chk2/Cdc25 process is likely to be less sensitive 
at inhibiting Cdk activity than the late p53/p21 process, 
consistent  with  previous  data  (Buscemi  et  al.,  2004). 
There are at least two possible explanations for the lower 
efficiency of the Chk2/Cdc25 process in comparison to 
the p53/p21 process. Firstly, in contrast to p21, inactiva-
tion of Cdc25 inhibits the further activation of Cdks but 
does not inhibit Cdks which are already activated, poten-
tially limiting its efficacy in late G1 phase. Secondly, the 
initial release of E2F at the restriction point defined by 
mitogen starvation initiates a positive feedback loop that 
increases Cdk2 activity which may be difficult to inhibit 
efficiently.  Thus,  both  possibilities  might  result  in  a 
reduced but not abolished rate of pRb phosphorylation. 
However, the response appears unable to affect all cells 
as, even after high doses (10 Gy), only a modest slowing 
in S-phase entry is observed. This is difficult to explain 
solely by an inefficient Chk2/Cdc25 process and suggests 
that as cells near the point of S-phase entry, an increasing 
fraction of cells have traversed the point of full pRb phos-
phorylation and can no longer respond to DNA damage 
(NB: this point is different to the restriction point defined 
by mitogen starvation). Consistent with this, the magni-
tude of the response (i.e. the fraction of cells undergo-
ing arrest) appears to diminish the closer the cells are 
to the time of S-phase entry. The existence of a time gap 
between full pRb phosphorylation and S-phase entry is 
also consistent with the notion that E2F, once released 
from pRb, transcriptionally activates factors needed for 
S-phase entry, a process which likely requires a signifi-
cant amount of time.
In summary, during the first 4–6 h after IR exposure, 
there  is  a  slowing  but  not  full  inhibition  of  S-phase 
entry and further studies are required to gain insight 
into  the  mechanistic  explanation.  Factors  including 
differing sensitivity between the Chk2/Cdc25 and p53/
p21 pathways, differing sensitivities of the cells behind 
and ahead of the restriction point and possibly differ-
ing  durations  between  cells  in  their  timing  of  entry 
after reaching the point of full pRb phosphorylation 
may contribute.
G1/S checkpoint maintenance, release and 
chromosome break formation
As  discussed  above,  several  hours  after  IR,  human 
fibroblasts display a full blockage of S-phase entry. This 
p53-dependent  G1/S  checkpoint  is  considered  to  be 
highly sensitive, possibly responding to a single unre-
paired DSB (Di Leonardo et al., 1994; Wahl et al., 1997; 
Yamauchi et al., 2008). Despite this, chromosomal stud-
ies have shown that irradiation of p53-proficient G0/G1 
cells can result in chromosome break formation in G2 or 
mitosis. Chromosome breaks (as opposed to chromatid 
breaks) are considered to arise when G0/G1-irradiated 
cells replicate across a DSB manifesting the breaks on 
both chromatids at the same location. How can this be 
explained if the G1/S checkpoint is responsive to a single 
DSB?  Serum-starved  cells  that  are  irradiated  immedi-
ately following serum addition undergo complete G1/S 
checkpoint arrest but can subsequently enter S phase 
(Deckbar et al., 2010). Under these conditions, the dura-
tion of checkpoint arrest was dose dependent and, after 
checkpoint release, the rate of S-phase entry was similar 
to that of untreated cells (Figure 2). Thus, the p53-depen-
dent G1/S checkpoint not only functions to permanently 
arrest damaged cells but can also function transiently 
to  enhance  the  time  for  repair  (which  we  estimate  to 
be ~6 h after 1 Gy). Interestingly, DSB repair measure-
ments by γH2AX and 53BP1 foci analysis indicate that, 
although these cells had repaired the majority of DSBs 
when they commence S-phase entry, they had not com-
pletely reached the background damage level of unirra-
diated cells. Thus, the p53-dependent G1/S checkpoint 
is indeed very sensitive to low damage levels but cells 
released from it harbor unrepaired damage (possibly 1–3 
DSBs). Additionally, after high doses, when the majority 
of  cells  undergo  prolonged  (and  possibly  permanent) 
arrest, a small fraction of cells can escape arrest, enter S 
phase and progress to G2 phase with substantial levels 
of unrepaired damage. It is possible that the analysis of 
mitotic chromosome breakage after high doses selects 
for such cells.
The fact that chromosome breaks arise after IR in G0/
G1 also requires a consideration of the sensitivity of the 
S-phase checkpoints. It is generally assumed that chromo-
some breaks (as compared to chromatid breaks) are the 
outcome of a DSB that has been duplicated in the course 
of replication. This implies that the intra-S checkpoint 
is inefficient in preventing replication of broken DNA. 
This is most obviously demonstrated by the observation 
that S-phase cells irradiated with high doses are able to Limitations of radiation-induced cell cycle checkpoints  277
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complete replication within a few hours. Furthermore, 
irradiated  S-phase  cells  enter  mitosis  at  similar  times 
to irradiated G2-phase cells, indicating that the intra-S 
checkpoint does not provide any significant additional 
repair time (Deckbar et al., 2007; Krempler et al., 2007; 
Fernet et al., 2010).
G2/M transition
The protein complex that drives mitotic entry is CyclinB1/
Cdk1. Transcription factors regulating CyclinB1 are acti-
vated  by  Cdks  ensuring  that  transcription  of  CyclinB1 
only takes place in the presence of active CyclinA/Cdk2. 
Thus,  transcription  of  CyclinB1  starts  in  S  phase  and 
peaks in late G2 (reviewed in Fung & Poon, 2005). In 
mammalian cells, Cdk1 levels are generally higher than 
CyclinB1  levels.  Thus,  the  presence  of  CyclinB1  and, 
therefore, the possibility to form a complex is the limit-
ing factor for mitotic entry (Arooz et al., 2000). During 
G2, the CyclinB1/Cdk1 complex is held in an inactive 
state  through  phosphorylation  of  Tyr15  and  Thr14  by 
the Wee1 and Myt1 kinases (Nigg, 2001). For activation 
and entry into mitosis, dephosphorylation of Cdk1 by the 
Cdc25 phosphatases is required. Thus, the regulation of 
CyclinB1/Cdk1 is performed by the opposing activities of 
Wee1 and Cdc25 (Figure 3).
In interphase cells, CyclinB1/Cdk1 is retained in the 
cytoplasm through permanent nuclear export. Located 
at the centrosomes, it is held in an inactive state by Chk1-
dependent inhibition of Cdc25 to prevent unscheduled 
cell  division  (Krämer  et  al.,  2004;  Loffler  et  al.,  2006). 
Centrosomally  located  CyclinB1/Cdk1  is  initially  acti-
vated  at  the  centrosomes  shortly  before  they  start  to 
migrate apart and rapidly translocates into the nucleus 
(Hagting et al., 1998; De Souza et al., 2000; Jackman et al., 
2003; Loffler et al., 2006). Once activated, CyclinB1/Cdk1 
phosphorylates Wee1 and Cdc25, inactivating Wee1 and 
activating Cdc25, which causes canonical activation of 
further CyclinB1/Cdk1 complexes. Thus, by inactivating 
its own inhibitor and activating its activator, CyclinB1/
Cdk1 is the central component of a positive feedback loop 
that ensures full and committed mitotic entry (reviewed 
in Lindqvist et al., 2009; Figure 3).
The  activation  of  Cdk1  has  wide-ranging  conse-
quences.  Firstly,  activated  Cdk1  phosphorylates  Wee1 
which mediates Plk1 recruitment and subsequent Plk1-
dependent phosphorylation of Wee1. The dual phospho-
rylation of Wee1 (i.e. Cdk1 and Plk phosphorylations) 
results in its poly-ubiquitination and proteasomal deg-
radation (Watanabe et al., 2004; Watanabe et al., 2005). 
In parallel, Plk1 phosphorylates Cdc25 contributing to 
its nuclear accumulation. Recent studies demonstrated 
Figure 3.  G2/M transition and G2/M checkpoint induction. Entry into mitosis is triggered by an active CyclinB1/Cdk1 complex. The 
activity of the CyclinB1/Cdk1 complex is tightly regulated by opposing feedback loops (indicated in green)—one involving the kinases, 
Myt1 and Wee1, and the other the phosphatase Cdc25, the first phosphorylating and inhibiting CyclinB1/Cdk1 and the latter removing 
these phosphorylations. Plk1 is involved in both feedback loops. After DNA damage induction, two ATM-dependent checkpoint pathways 
are activated (indicated in blue). The checkpoint kinases, Chk1/Chk2, target Cdc25 for nuclear export leading to the accumulation of the 
inactive CyclinB1/Cdk1 complex. Further inhibition of CyclinB1/Cdk1 takes place through a slowly activated p53-dependent pathway. The 
lack of activated CyclinB1/Cdk1 interrupts the feedback loops (dotted lines), resulting in G2 arrest. (See colour version of this figure online 
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that the initial phosphorylation of Plk1 at the G2/M tran-
sition is conducted by Aurora-A kinase (Macurek et al., 
2008; Seki et al., 2008; Macurek et al., 2009). Activation 
of  Aurora-A  requires  Bora  which  is  also  activated  by 
Cdk1. Thus, Cdk1 phosphorylates Bora leading to fur-
ther activation of Plk1 (Hutterer et al., 2006; Chan et al., 
2008). Thus, in a second feedback loop, CyclinB1/Cdk1 
stimulates its own activation by enhancing the activity 
of  its  own  activators.  Furthermore,  dephosphorylation 
of Aurora-A by PP1 results in its inactivation (Katayama 
et al., 2001; Marumoto et al., 2002). Here, again, CyclinB1/
Cdk1 affects its own activation by regulating PP1 activity. 
Having reached a certain level in late G2/early mitosis, 
CyclinB1 contributes to the activation of the multisub-
unit  E3  ligase  APC/C  promoting  its  own  proteosomal 
degradation ensuring low expression levels at the begin-
ning of the new cell cycle (Fung & Poon, 2005; Lindqvist 
et al., 2007).
In summary, a whole network of positive and dou-
ble-negative feedback loops exists for the activation of 
CyclinB1/Cdk1. It has been proposed that this activation 
occurs  continuously  during  the  progression  through 
S and G2 phase. The feedback loops warrant that after 
CyclinB1/Cdk1  is  activated  above  a  certain  threshold 
level,  further  activation  increases  rapidly  and  initiates 
the subsequent cell division.
G2/M checkpoint activation
Before CyclinB1/Cdk1 has reached a critical level, cells 
can  respond  to  DNA-damaging  agents  by  interfering 
with the feedback loops that lead to further activation of 
CyclinB1/Cdk1. DSBs, for example, activate ATM which 
phosphorylates effector proteins and initiates cell cycle 
arrest.  The  molecular  mechanisms  are  very  similar  to 
those of the G1/S checkpoint and have been presented 
in various reviews (Lukas et al., 2004; Sancar et al., 2004; 
Warmerdam & Kanaar, 2010). Briefly, active ATM phos-
phorylates Chk2 which, in turn, phosphorylates Cdc25, 
leading  to  cytoplasmic  translocation  of  Cdc25  and 
maintained  inhibition/inactivation  of  CyclinB1/Cdk1 
(Figure 3). Thus, this pathway consists of posttranslational 
modifications  resulting  in  rapid  G2  arrest.  Although  a 
p53-dependent pathway which involves the transactiva-
tion of Cdk-inhibiting proteins has been described, the 
exact function of this pathway in regulating G2/M arrest 
is not fully understood (Chan et al., 2000; Taylor & Stark, 
2001; Lukas et al., 2004; Bruno et al., 2006).
One function of a checkpoint is to halt cell cycle pro-
gression until the completion of DSB repair or until the 
environmental conditions are optimal for cell cycle pro-
gression (and cell division in the case of the G2/M check-
point). Nevertheless, a phenomenon has been reported 
that allows cell division in the presence of unrepaired DSBs. 
This process was originally described in Saccharomyces 
cerevisiae  and  demonstrates  that  yeast  cells  carrying  a 
dispensable chromosome without a telomere (which rep-
resents a DSB) first undergo G2 arrest but subsequently 
abrogate the checkpoint and undergo division (Sandell & 
Zakian, 1993). This process was termed adaptation and 
has  been  suggested  to  cause  genomic  rearrangements 
and genomic instability (Sandell & Zakian, 1993; Toczyski 
et  al.,  1997;  Galgoczy  &  Toczyski,  2001).  A  unicellular 
organism, which has to adjust to changing environmental 
conditions, may benefit from this but adaptation has also 
been demonstrated in Xenopus egg extracts (Yoo et al., 
2004) and has been suggested to exist also in human cells. 
Indeed,  using  G2/M  checkpoint-proficient  tumor  cells, 
it has been demonstrated that tumor cells can divide in 
the presence of unrepaired DSBs several hours after IR 
and G2/M checkpoint activation (Syljuåsen et al., 2006; 
Syljuåsen, 2007).
Additional insight into G2/M checkpoint regulation 
after  IR  was  provided  by  recent  studies  with  normal 
human  fibroblasts  which  demonstrated  that  mitotic 
entry  occurs  prior  to  the  completion  of  DSB  repair 
(Deckbar et al., 2007). Thus, mitotic entry in the pres-
ence of unrepaired DSBs is not restricted to tumor cells 
but represents a physiological process that occurs even 
in  nontransformed  cells.  However,  examination  of  the 
kinetics of mitotic entry after different doses in repair-
proficient as well as repair-deficient cells demonstrated 
that cells are released from G2 arrest once their level of 
DSBs has fallen below a certain threshold. Surprisingly, 
this threshold is not a single DSB, the level necessary to 
arrest cells until the completion of DSB repair, but rather 
the  G2/M  checkpoint  is  abrogated  in  the  majority  of 
cells when they harbor between 10–20 unrepaired DSBs 
(Figure 4). The finding of a defined threshold was surpris-
ing and appeared to be inconsistent with chromosomal 
studies reporting a dose-dependent increase in mitotic 
chromosome  breakage.  However,  these  studies  assess 
the level of chromosome breakage at a defined time point 
post irradiation and do not consider the response of the 
majority of cells that undergo checkpoint arrest. Indeed, 
most cells undergo arrest and are released within a similar 
time frame, with the duration of arrest being dose depen-
dent. Thus, at any defined time point post irradiation, the 
level of chromosome breaks increases with dose, but at 
the specific time when the majority of cells enter mito-
sis (i.e. when checkpoint arrest is released), the number 
of chromosomal breaks in mitosis is dose independent 
(Löbrich & Jeggo, 2005; Jeggo & Löbrich, 2006).
In summary, the G2/M checkpoint transiently arrests 
heavily damaged cells in G2 to provide time for repair 
but does not completely prevent cell division in the pres-
ence of unrepaired DSBs, allowing cells to enter mito-
sis with a significant number of DSBs (Figure 4). Thus, 
although being rapidly activated (in contrast to the G1/S 
checkpoint),  the  G2/M  checkpoint  also  has  inherent 
insensitivity.
G2/M checkpoint termination
In  contrast  to  the  number  of  studies  addressing  the 
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about the biochemical mechanisms underlying the ter-
mination of G2 checkpoint arrest and the resumption of 
cell cycle progression. More recently, however, check-
point termination became the subject of several investi-
gations. In principle, there are two distinct mechanisms 
underlying  checkpoint  termination.  Protein  phos-
phatases such as Wip1, PP2A, PP4 or PP6 counteract 
the activity of the checkpoint activating kinases, ATM 
and  ATR,  by  removing  phosphates  from  Chk1,  Chk2, 
p53 and the damage signal amplifying histone variant 
H2AX (Goodarzi et al., 2004; Lu et al., 2005; Shreeram 
et al., 2006; Nakada et al., 2008). In the course of repair, 
the checkpoint activating signal decreases shifting the 
balance  between  activating  and  inactivating  signals 
toward inactivation. Once the cell has repaired below a 
certain DSB level, phosphatase activities dominate over 
the kinase activities and boost the process of checkpoint 
termination. Indeed, depletion of these phosphatases 
results in impaired checkpoint termination. The second 
possibility underlying checkpoint termination involves 
the  activation  of  pathways  during  checkpoint  arrest 
which counteract the checkpoint activation pathways. 
The first studies which shed light on the existence of 
such active pathways were again performed in yeast. 
The adaptation  process  described  above  depends  on 
at least three genes: the polo-like kinase Cdc5 and two 
genes encoding the casein kinase II subunits Ckb1 and 
Ckb2 (Toczyski et al., 1997). The single-stranded DNA 
(ssDNA) binding protein, RPA, as well as Ku70, Mre11 
and Rad50 which affect the generation of ssDNA, were 
also suggested to regulate checkpoint adaptation (Lee 
et  al.,  1998).  Studies  using  replication  stress  for  DSB 
induction in aphidicolin-treated Xenopus egg extracts 
extended the list of potential key players in the process 
of adaptation to DNA damages to Plx1 (human Plk1), 
Claspin and Chk1 (Yoo et al., 2004). Aphidicolin-treated 
egg extracts initiate a G2/M checkpoint response and 
undergo  adaptation  after  several  hours.  Claspin  was 
originally  described  as  a  Chk1-interacting  protein. 
During replicational stress (which occurs after aphidi-
colin  treatment),  Claspin  binds  to  chromatin  and  is 
essential  for  the  phosphorylation  and  activation  of 
Chk1 in Xenopus and human cell systems (Kumagai & 
Dunphy, 2000; Chini & Chen, 2004). Claspin becomes 
phosphorylated at Thr906 in an ATR-dependent man-
ner, which creates a docking site for Plx1 enabling Plx1 
to phosphorylate Claspin on Ser934. In the course of 
checkpoint adaptation, despite the persisting replica-
tional  stress,  Claspin  is  progressively  phosphorylated 
in a Plx1-dependent manner, resulting in the release of 
Claspin from the chromatin and finally the inactivation 
of Chk1 (Yoo et al., 2004).
The  events  leading  to  checkpoint  termination  are 
even more complex as the ubiquitin ligase SCF-βTrCP 
regulates  two  opposing  effects.  On  one  hand,  SCF-
βTrCP ubiquitinylates Cdc25a triggering its degradation, 
resulting  in  checkpoint  activation  after  replicational 
stress.  On  the  other  hand,  it  ubiquitinylates  Claspin 
resulting in Claspin degradation and thus Chk1 inacti-
vation (Mailand et al., 2006). Again, the switch from a 
cell cycle inhibitory to a cell cycle promoting mode of 
βTrCP has been suggested to be mediated by Plk1 which 
Figure 4.  Limitations of the G2/M checkpoint. The activation of the G2/M checkpoint is a fast but insensitive process. Low-dose irradiation 
fails to completely prevent entry into mitosis resulting in many cells entering mitosis with double-strand breaks (DSBs). Higher doses 
(≥0.5–1 Gy) fully initiate the G2/M checkpoint with only a few cells escaping arrest. The duration of the G2 arrest increases with dose. 
However, the G2/M checkpoint is not maintained until the completion of DSB repair but cells are released when they harbor 10–20 γH2AX 
foci. This limitation results in many cells entering mitosis with a substantial amount of unrepaired DSBs. The figure depicts entry into 
mitosis of asynchronously irradiated cells. pSer10-H3 was used to assess mitotic cells at various times post irradiation. (See colour version 
of this figure online at www.informahealthcare.com/bmg)280  D. Deckbar et al.
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phosphorylates  the  N-terminus  of  Claspin  promoting 
its  SCF-βTrCP-dependent  ubiquitinylation  and  degra-
dation.  Furthermore,  Plk1  triggers  βTrCP-dependent 
ubiquitinylation and degradation of the Cdk1-inhibiting 
kinase Wee1.
The studies above address G2/M checkpoint termi-
nation after replication stress involving ATR, Chk1 and 
Wee1. However, DSBs are primarily sensed by ATM and 
Chk2.  Currently,  little  is  known  about  G2/M  check-
point termination after DSB induction. It has recently 
been  demonstrated  that  Cdk1  phosphorylates  53BP1 
at  Ser380,  a  highly  conserved  Plk1  Polo-Box  Domain 
(PBD)-binding site (van Vugt et al., 2010). Upon phos-
phorylation, Plk1 binds 53BP1 which serves as a binding 
platform for Chk2. Subsequently, Plk1 phosphorylates 
the forkhead-associated (FHA) domain of Chk2 which 
results  in  Chk2  inactivation.  Furthermore,  53BP1  (as 
well as pATM) does not form DDR foci during mitosis 
preventing  sustained  damage  signaling.  In  this  way, 
53BP1 could play a central role in checkpoint termina-
tion, with phosphorylation of 53BP1 impacting on both 
the  efficient  maintenance  of  ATM  signaling  and  the 
downstream signaling via Chk2. However, there are dif-
ficulties with the model that phosphorylation of 53BP1 
promotes checkpoint termination. Firstly, it is unclear 
whether the release of 53BP1 from the DSB site is a con-
sequence or the cause of checkpoint termination. We 
have observed that 53BP1 foci can be detected reliably 
until early prophase and that 53BP1 release from chro-
matin occurs concomitantly with chromatin condensa-
tion (unpublished data). This would imply that 53BP1 
release from the chromatin does not promote checkpoint 
termination but rather represents the consequence of 
chromatin  condensation  during  mitotic  entry.  A  sec-
ond difficulty is that cells lacking 53BP1 undergo inef-
ficient checkpoint arrest at low doses and premature 
checkpoint release after high doses, i.e. the opposite of 
what would be predicted from a model in which 53BP1 
is  required  for  the  termination  of  checkpoint  arrest 
(Fernandez-Capetillo et al., 2002; Shibata et al., 2010). 
Finally, in this context, it is worth mentioning the role of 
γH2AX foci formation in both the initiation and main-
tenance of checkpoint arrest. Cells lacking H2AX are 
able to effect checkpoint arrest at all but low IR doses 
(Fernandez-Capetillo et al., 2002; Shibata et al., 2010). 
They also fail to maintain arrest efficiently. The findings 
suggest that the foci have an amplification role which is 
solely required at low doses. Surprisingly, despite this 
process to enhance signaling at low doses, cells remain 
insensitive to G2/M checkpoint arrest when less than 
15–20 DSBs remain.
The transition from G2 into mitosis is a tightly regu-
lated process consisting of positive and negative feed-
back  loops  which  target  the  activity  of  the  CyclinB1/
Cdk1  complex,  and  it  is  likely  that  entry  into  mitosis 
occurs when the activating signals dominate over the 
inhibitory signals.
Interplay between DSB repair in G2 and the 
G2/M checkpoint
The G2/M checkpoint signal is essentially dependent on 
active Chk1 and Chk2 as the addition of Chk1/2-inhibiting 
drugs after checkpoint initiation results in abrogation of 
the G2 arrest within 1 h (Shibata et al., 2010). However, 
G2/M checkpoint signaling can be modified during DSB 
repair. In G2-irradiated cells, about 20% of IR-induced 
DSBs are repaired with slow kinetics representing those 
DSBs that undergo resection and repair via HR (Beucher 
et al., 2009). Resected ssDNA regions are rapidly coated 
with RPA leading to a switch from ATM to ATR activation 
(Zou & Elledge, 2003; Shiotani & Zou, 2009). However, 
as resection is dependent on ATM, ATR activation and 
G2/M checkpoint induction relies on ATM (Jazayeri et al., 
2006). ATM and ATR predominantly signal to Chk2 and 
Chk1, respectively. As resection can be initiated at early 
times post IR, Chk1 and Chk2 have overlapping roles in 
checkpoint  initiation  (López-Contreras  &  Fernandez-
Capetillo, 2010; Shibata et al., 2010). At early times post 
IR, the majority of DSBs are unresected; thus, it is pos-
sible, although it has not been definitively shown, that 
ATM/Chk2 plays the major role in checkpoint initiation. 
However, Chk2−/− mouse embryonic fibroblast cultures 
(MEFs) are proficient in checkpoint induction, suggest-
ing that Chk1 can fully compensate for the loss of Chk2 
(Fernandez-Capetillo et al., 2002). At later times post IR, 
the ratio of resected versus unresected DSBs increases 
as the repair of unresected DSBs by NHEJ is a fast pro-
cess. This, in turn, results in a greater contribution of 
ATR and Chk1 to the maintenance of checkpoint arrest. 
Thus, ATR/Chk1-deficient cells exhibit premature G2/M 
checkpoint release (Shibata et al., 2010).
Given that cells are released into mitosis before the 
completion of DSB repair, it is important to consider the 
consequences of this limitation. One consequence is the 
appearance of chromosomal breaks in mitosis which can 
lead to loss of genetic material and cell death. Additionally, 
as mentioned above, HR represents the slow component 
of DSB repair in G2 (Beucher et al., 2009). This suggests 
that at the time of checkpoint release, the remaining DSBs 
represent those undergoing repair by HR. Thus, it is pos-
sible that cells enter mitosis with resected DSBs as well as 
with hetero-duplexes and unresolved Holliday Junctions. 
Anaphase bridges are microscopically visible chromatin 
connections between the chromatids of the two daughter 
cells and represent markers for chromatin entanglements 
(Hoffelder et al., 2004). If not resolved in time, anaphase 
bridges can break in later stages of mitosis and lead to 
the de novo formation of DSBs. Observations from our 
lab indicate that X-irradiation of G2-phase cells increases 
the number of anaphase bridges in mitosis (unpublished 
data). Thus, another consequence of the insensitivity of 
the G2/M checkpoint could be the formation of anaphase 
bridges which result in the formation of de novo DSBs 
and micronuclei. Recent observations strengthen these Limitations of radiation-induced cell cycle checkpoints  281
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suggestions by demonstrating that cells entering mitosis 
with DNA damages induced by replicational stress dis-
played elevated levels of 53BP1 foci in the following G1 
phase (Lukas et al., 2011).
The cooperation of cell cycle checkpoints in 
the prevention of chromosomal instability
As discussed, cell cycle checkpoints have significant limi-
tations. The G1/S checkpoint fails to prevent cells with 
DSBs from entering S phase within the first hours after 
irradiation. Such cells exhibit significantly elevated levels 
of unrepaired DSBs in G2 as well as chromosome breaks. 
As  the  G2/M  checkpoint  is  insensitive  below  10–20 
DSBs, cells undergo mitosis with unrepaired DSBs which 
can result in loss of genetic material. Thus, neither the 
intra-S nor the G2/M checkpoint can compensate for the 
limitation of the G1/S checkpoint. However, it has been 
observed that following one round of cell division, cells 
irradiated in G1 are temporarily or permanently arrested 
in the following G1 phase (Linke et al., 1997a; Wahl et al., 
1997; unpublished data). Interestingly, this was the case 
for cells that had been irradiated in late G1 and failed 
to arrest as well as for cells that had initiated and sub-
sequently been released from the G1/S checkpoint. This 
second round arrest process is p53 dependent suggesting 
that the most prominent role of p53 might be the regula-
tion of DNA damage-activated processes over multiple 
cell cycles. It is possible that this mechanism eliminates 
cells with irreparable damage from the actively prolifer-
ating population (Wahl et al., 1997; Petersen et al., 2010).
Multicellular  organisms  aim  to  achieve  a  balance 
between cell survival and the risk of developing chro-
mosomal instability. DSB-activated checkpoints gener-
ally provide time for repair but there appears to be a 
need that they are limited in their efficiency. It has to 
be appreciated that even in an unperturbed cell cycle, 
DSBs are induced by products of the oxidative metabo-
lism, during the course of replication and, in some cell 
types, in a programmed manner. One possible explana-
tion for the need for inefficiency is that if checkpoints 
were  too  tight,  the  risk  of  developing  chromosomal 
instability would be minimized but at the cost of limit-
ing the ability of cells to proliferate, and consequently 
the survival of an organism. However, if checkpoints 
were too negligent, cells would be able to proliferate in 
the presence of damage but be at risk for developing 
chromosomal instability and cancer.
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